Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001571049-17-006442
Filing Date
2017-06-30
Accepted
2017-06-30 17:17:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 t1701721-s1a.htm S-1/A 666408
2 EXHIBIT 1.1 t1701721_ex1-1.htm EX-1.1 234873
3 EXHIBIT 3.5 t1701721_ex3-5.htm EX-3.5 114546
4 EXHIBIT 4.2 t1701721_ex4-2.htm EX-4.2 12558
5 EXHIBIT 4.3 t1701721_ex4-3.htm EX-4.3 114436
6 EXHIBIT 5.1 t1701721_ex5-1.htm EX-5.1 13453
7 EXHIBIT 23.1 t1701721_ex23-1.htm EX-23.1 2412
8 GRAPHIC lg_cyclacel-withregmark.jpg GRAPHIC 124046
9 GRAPHIC t1701721_ex5-1logo.jpg GRAPHIC 5427
  Complete submission text file 0001571049-17-006442.txt   1338418
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-218305 | Film No.: 17943131
SIC: 2834 Pharmaceutical Preparations